Tropical Weight Loss
Tropical Weight Loss
Photo: Amina Filkins
The FDA approved Ozempic for a 2.0 mg dose, which was based on clinical trial data showing the higher dose led to a better A1C and to weight loss. The FDA recently approved Novo Nordisk's 2.0 mg dose of the once-weekly injectable Ozempic (semaglutide) based on results from the SUSTAIN FORTE clinical trial.
Limit sugar and sugar-sweetened drinks. A diet high in added sugars may lead to excess abdominal fat. ... Eat more protein. Protein may be the most...
Read More »
Caffeine blocks melatonin signaling/transmission [20]. Jul 28, 2020
Read More »The FDA approved Ozempic for a 2.0 mg dose, which was based on clinical trial data showing the higher dose led to a better A1C and to weight loss. The FDA recently approved Novo Nordisk’s 2.0 mg dose of the once-weekly injectable Ozempic (semaglutide) based on results from the SUSTAIN FORTE clinical trial. Ozempic 2.0 mg, a GLP-1 receptor agonist, previously only available at the 0.5 mg and 1.0 mg doses, is now approved for type 2 diabetes and to reduce the risk of heart attack, stroke, or cardiac death in adults with type 2 diabetes and with heart disease. The SUSTAIN FORTE clinical trial showed better outcomes over 40 weeks for the 2.0 mg dose compared to the 1.0 mg dose. However, negative gastrointestinal side effects did occur more frequently among patients receiving the higher dose (34% compared to 30.8%). 2.0 mg dose group 1.0 mg dose group Average A1C at the start of the Trial 8.9% 8.8% Average A1C at 40 weeks 6.7% 6.9% Average reduction in A1C 2.2 percentage points 1.9 percentage points Percent of group achieving an A1C of 6.5% or lower 52% 39% Percent of group who had at least 5% weight reduction 59% 51% Percent of group who had at least 10% weight reduction 28% 23% Two other drugs, Rybelsus or Wegovy, are similar to Ozempic; all three of these medications are different forms of semaglutide. Rybelsus is a daily pill for people with type 2 diabetes while Wegovy is a 2.4 mg once-weekly injection for treating obesity. Having an additional dosing option for Ozempic will give healthcare providers and people with diabetes an additional alternative to personalize treatment based on their health goals. In addition, not all health insurance plans cover obesity treatment, so people with diabetes and excess weight or obesity may not have been able to access Wegovy with the higher dose of semaglutide. Because Ozempic is already an established diabetes medication covered by most insurance plans and Medicare, access to a higher dose may not be a problem. Novo Nordisk has said that it hopes to make the 2.0 mg dose of Ozempic available in the US in the next few months. This dosing option is also approved in Canada, Switzerland, and Europe.
Drinking lemon water before meals may help promote and improve digestion. That's because the citric acid found in lemon juice has been shown to...
Read More »
Some fat burner supplements have been linked to problems like liver damage. Some herbs, like ephedra, that were once used in fat burners are now...
Read More »Staying on Saxenda® (disp: 5 pens) EHR, electronic health record.
Celebrities Are Apparently Taking Ozempic, a Drug Intended for Diabetes, to Help Them Lose Weight Rapidly—But Is That Safe? It's been rumored that...
Read More »
Perilla Targets Inflammation: Joins Traditional Gut Nutrients as Potent Anti-spasmodic and Anti-inflammatory. Nov 20, 2014
Read More »
For weight loss and muscle gain Since milk is rich in protein, it may aid weight loss and muscle building. Protein-rich foods like milk can boost...
Read More »
Health Benefits of Sleeping Without Underwear Sleeping with covers, tight-fitting pajamas or clothes, and underwear can lead to even more moisture...
Read More »
Promotion
Promotion